Advocacy surrounding the development of pharmaceuticals for animals and tariff exclusions for the same.
2026 · 2nd Quarter (Apr 1 - June 30)
ELANCO ANIMAL HEALTH
Filed by BROWNSTEIN HYATT FARBER SCHRECK, LLP.
Open official filingSource-reported fields
Filing overview
- Type
- Registration
- Posted
- Jul 6, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- BROWNSTEIN HYATT FARBER SCHRECK, LLP
- Client
- ELANCO ANIMAL HEALTH
- Filing UUID
- fbc37ca6-a009-4496-876b-4d0fa8150165
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Advocacy surrounding the development of pharmaceuticals for animals and tariff exclusions for the same.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.